Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail

Dermatol Ther. 2012 May-Jun;25(3):283-5. doi: 10.1111/j.1529-8019.2012.01465.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Biological Products / therapeutic use*
  • Dermatitis, Exfoliative / drug therapy*
  • Dermatitis, Exfoliative / etiology
  • Humans
  • Male
  • Middle Aged
  • Psoriasis / complications
  • Psoriasis / drug therapy*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / therapeutic use
  • Ustekinumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biological Products
  • Tumor Necrosis Factor-alpha
  • Ustekinumab